Eosinophilic Granulomatosis with Polyangiitis (EGPA) Treatment Market

Key Players

  • Allakos Inc
  • Amgen
  • BlackRock
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Bristol Myers Squibb (BMS) Company
  • Celgene Corporation
  • GSK
  • Novartis
  • Regeneron Pharmaceuticals
  • Roche
  • L'Oréal
  • Teva Pharmaceuticals
  • Teva Pharmaceuticals (Israel)
  • Viela Bio
Future Market Insights

Eosinophilic Granulomatosis with Polyangiitis (EGPA) Treatment Market